Navigation Links
Using green chemistry to deliver cutting-edge drugs
Date:9/13/2007

Green chemistry is being employed to develop revolutionary drug delivery methods that are more effective and less toxic and could benefit millions of patients.

Chemists at The University of Nottingham are developing new methods for coating drugs in plastics, using methods that do not damage the latest generation of delicate biopharmaceutical drugs which are at the cutting edge of modern medical treatment.

Conventional methods of coating drugs can use high temperatures and harsh solvents damaging the active components of biopharmaceuticals before they have even reached the patient. But using green chemistry techniques pioneered at Nottingham, the bioactive elements of the drug remain completely effective, so the patient receives the maximum benefit of the therapy. The plastic is designed to release the drug over a controlled period of time; minimising the number of injections a patient will need, and maximising the effect of the drug.

The principles of green chemistry herald a radical new approach that is benign by design both in terms of the process itself, its impact on patients and on the environment. Green chemistry promises to make the chemical industry cleaner and safer, while producing better, purer products in the process.

In a presentation at the British Association for the Advancement of Science Conference in York on September 12, Professor Steve Howdle outlined the green chemistry processes being pioneered at The University of Nottingham, particularly the use of supercritical fluids to replace conventional solvents such as benzene and chloroform.

Professor Howdles research focuses on exploiting the unique properties of supercritical carbon dioxide (CO2). A supercritical fluid is a solvent, with physical properties between those of a gas and a liquid. At near-room temperature and under modest pressure, supercritical carbon dioxide blurs the boundaries between liquid and gaseous states.

The proces
'/>"/>

Contact: Professor Steve Howdle
steve.howdle@nottingham.ac.uk
University of Nottingham
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
2. Purdue proves concept of using nano-materials for drug discovery
3. An entropy-based gene selection method for cancer classification using microarray data
4. Newly Discovered Compound Blocks Known Cancer-Causing Protein
5. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
6. New methods of gene delivery using lasers
7. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
8. Doctors closer to using gene analysis to help trauma patients
9. PHACCS, an online tool for estimating the structure and diversity of uncultured viral communities using metagenomic information
10. Researchers pioneer new gene therapy technique using natural repair process
11. Researchers Closer To Helping Hearing-Impaired Using Stem Cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009).... Louis, MO, November 4, 2009 Childhood obesity i...ns. With more than one fourth of advertising on da...nd beverages and continuing questions about the ro...ember/December issue of the Journal of Nutrition ...ing aimed at children might be a large contributor...
(Date:11/4/2009)..., PORTOLA VALLEY, Calif., Oct. 19 ...olecular sensing and imaging devices which shed li...that it has signed exclusive distribution deals fo...nsors. The markets covered include Australia, New...enelux), Suriname, Italy, France, Spain, Portugal,...
(Date:11/4/2009)..., RIDGE, N.Y., Oct. 21 What,s the ...eventing accidental death resulting from prescript...s with good intentions, however, may be unaware th...ting their teens from the ticking timebomb of pres...leader in premium-quality medical supplies, has fo...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3AMA Medicare Campaign Kicks Off With New TV Ads 59585 1AMA Medicare Campaign Kicks Off With New TV Ads 59585 2AMA Medicare Campaign Kicks Off With New TV Ads 59585 3Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 1Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 2ViroPharma to Release 2009 Third Quarter Financial Results on October 28 2009 59581 1ViroPharma to Release 2009 Third Quarter Financial Results on October 28 2009 59581 2
...of Standards and Technology (NIST) last week issue... and growing field of tissue engineering for medic...al tissue scaffold material that have been measure...es of porosity. , Three-dimensional tissue scaffo...adable materials that are meant to be implanted in...
...nt pieces of the climate change puzzle together is...is a key piece of this puzzle, but the size and sh...opardises the reliability of all current predictio...ct has been launched at the University of Leeds to...te. , Aerosols are small particles suspended in...
...f melanin -- the color pigment in skin and hair --...sed susceptibility to nicotine dependence and toba...rs, according to scientists., "We have found that...to the number of cigarettes smoked daily, levels o... African Americans," said Gary King, professor of ...
Other Biology News:NIST issues first reference material for tissue engineering 2Aerosol: A key piece of the climate change puzzle 2Skin color clue to nicotine dependence 2
(Date:11/5/2009)...FREMONT, Calif., Nov. 5 ...S), a leading developer of state-of-the-art geneti...er Sears, Ph.D. has joined the company,s Scientifi...designing and commercializing novel molecular diag...s, and on the development of computational biology...
(Date:11/5/2009)... LASIK Surgery and vision corre... directory were actively involved at the recently ...2009 Annual Meeting in San Francisco, California. ...MD, Dr. Jonathan Davidorf, MD, Dr. Peter Rapoza, M..., Dr. R. Wayne Bowman, MD, Dr. Edward Manche, MD, ...
(Date:11/4/2009)...HUNTSVILLE, Ala., Nov. 4 DIATHERIX...om ), today presented at the Michigan Security Ne...ce in Dearborn, Mich. Dennis Grimaud, Chairman and...he impact of the company,s advanced molecular diag...nse, infectious disease diagnosis and military eff...
(Date:11/4/2009)...SAN CARLOS, Calif., Nov. 4 /PRNewswire-FirstCall/ ...rted its financial results for the third quarter e...uarter ended September 30, 2009 improved to $31.0 ...oss of $37.0 million or $0.40 per share in the thi...ake improvements to its operating efficiencies as ...
Breaking Biology Technology:WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9DIATHERIX Laboratories Presents at Homeland Security Conference 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
...ociates, Inc.,administrator for the HealthShares(T...the HealthShares(TM) Exchange-Traded Funds, today ... on Tuesday February 26, 2008, KV,Pharmaceutical C...ls, Inc.,(NYSE: BDY ) in the HealthShares(TM) Der...quired by Nycomed US Inc., a subsidiary of Nycomed...
...ration,(Nasdaq: BPUR ) today announced its financ...uary 31, 2008. For the quarter, the company report... share, compared with a net loss,of $6.9 million, ...eriod in,2007. Class A common shares outstanding o...,543,025, respectively., Revenues, Total revenue...
...ntered into an Agreement Under, Which Genmab Will ...ted in Brooklyn Park, Minnesot...ifornia, February 21, Genmab A/S (OMX: GEN) and PD... that they have entered into an agreement,under wh...ing facility,located in Brooklyn Park, Minnesota, ...
Other Biology Technology:Biopure Announces 2008 First Quarter Financial Results 2Biopure Announces 2008 First Quarter Financial Results 3Biopure Announces 2008 First Quarter Financial Results 4Biopure Announces 2008 First Quarter Financial Results 5Biopure Announces 2008 First Quarter Financial Results 6Biopure Announces 2008 First Quarter Financial Results 7Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 2Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 4Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 5
Anti-Mouse VEGF-C Antibody, Unconjugated from Raybiotech, Inc.
Annexin V Binding Buffer from BD Biosciences Pharmingen
Mouse Anti-Cytokeratin 8 + 18 + 19 Monoclonal Antibody, Unconjugated, Clone 2A4 from Abcam
Tube-O-DIALYZER Floats, Floats, Small from CHEMICON
Biology Products: